Exchange: NASDAQ·Updated 06:00 PM EDT
DAWN logo

DAWN Day One Biopharmaceuticals Inc

$21.53
$0.04
(0.19%)
Today
Closed $21.53
$0.03
(0.14%)
After Hours
Reported EarningsFeb 24
Mkt Cap$2.22B
Vol2.99M

About DAWN

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.
43

Bearish Sentiment

How do you feel about DAWN?

Advertisement|Remove ads.